8-K: Alphatec Holdings Announces Strong 2024 Revenue Growth and Positive 2025 Outlook

Alphatec Holdings reports a 27% revenue increase for 2024 and projects positive free cash flow for 2025.

Summary

• Alphatec Holdings, a spine surgery solutions provider, announced preliminary financial results for 2024.
• Full-year 2024 total revenue grew by approximately 27% to around $611 million.
• Surgical revenue for 2024 increased by 29%, driven by a 19% growth in surgical volume and an 8% increase in average revenue per procedure.
• The company's cash balance at the end of 2024 was approximately $139 million, a $58 million increase from the previous quarter.
• This includes $50 million from a term loan expansion.
• For 2025, the company anticipates total revenue of $732 million, representing a 20% growth compared to 2024.
• The 2025 revenue forecast includes approximately $657 million from surgical revenue and $75 million from EOS revenue.
• Alphatec expects adjusted EBITDA of approximately $75 million in 2025, leading to positive free cash flow for the year.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to strong revenue growth, improved cash position, and a promising outlook for 2025, including positive free cash flow. The company's management also expresses confidence in their strategy and future prospects.

Positives

• The company experienced strong revenue growth in 2024, with a 27% increase in total revenue.
• Surgical revenue grew by 29% in 2024, indicating strong adoption of their products.
• The company's cash balance significantly improved in Q4 2024, increasing by $58 million.
• Alphatec is projecting a 20% revenue growth for 2025, reaching $732 million.
• The company expects to achieve positive free cash flow in 2025, driven by an adjusted EBITDA of approximately $75 million.

Negatives

• The financial results for 2024 are preliminary and unaudited, subject to potential adjustments during the closing process.
• The company's non-GAAP financial measures may not be directly comparable to those of other companies in the industry.

Risks

• The preliminary financial results are subject to change upon completion of the annual audit.
• The company's future performance is dependent on the acceptance of its products by the surgeon community.
• There is a risk that the company may not achieve its projected revenue and profitability targets for 2025.
• The company's non-GAAP financial measures may not be directly comparable to those of other companies in the industry.

Future Outlook

The company anticipates full-year 2025 total revenue of $732 million, reflecting a 20% growth compared to 2024, and expects to achieve positive free cash flow driven by an adjusted EBITDA of approximately $75 million.

Management Comments

• Pat Miles, Chairman and Chief Executive Officer, stated that the company's dedication to revolutionizing spine surgery fueled another year of sector-leading growth and an inflection to profitability in 2024.
• Management believes that ATEC is uniquely applying 100% spine focus and industry-leading knowhow to avail more predictable, more durable spine care.
• Management believes that the company is exceptionally well positioned to self-fund the strategy that will further their success.

Industry Context

This announcement highlights Alphatec's strong performance in the spine surgery market, indicating a growing demand for their innovative solutions. The company's focus on integrating informatics into their approaches positions them well against competitors in the medical device industry.

Comparison to Industry Standards

• Alphatec's 27% revenue growth in 2024 is a strong performance compared to the broader medical device industry, which typically sees single-digit growth rates.
• Companies like Medtronic and Johnson & Johnson, while much larger, have not reported similar growth rates in their spine divisions.
• The projected 20% revenue growth for 2025 also indicates a strong trajectory compared to industry averages.
• The company's focus on innovation and integration of informatics is a differentiator compared to more traditional spine surgery companies.

Stakeholder Impact

• Shareholders are likely to react positively to the strong revenue growth and positive outlook.
• Employees may be motivated by the company's success and future prospects.
• Customers (surgeons) are likely to continue adopting the company's products due to their innovative nature.
• Suppliers may benefit from the company's increased sales and production.

Next Steps

• The company will report its full fourth quarter and full-year 2024 financial results on February 26, 2025.
• The company will host a live webcast on February 26, 2025, to discuss the results.

Key Dates

Keywords

spine surgery, medical devices, revenue growth, EBITDA, free cash flow, surgical revenue, financial outlook, Alphatec, ATEC